Dilated cardiomyopathy future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD [2]

Overview

New promising treatments for dilated cardiomyopathy include -among others- stem cell-based treatments, cholesterol-lowering drugs in combination with angiotensin receptor blockers, and protein A immunoadsorption.

Future or Investigational Therapies

There are several new therapies, currently under investigation for dilated cardiomyopathy. The most promising of these therapies include:

Stem cell-based treatments: Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC])
Cholesterol lowering drugs as Simvastatin or rosuvaststin, alone or in combination with angiotensin receptor blockers as valsartan or olmesartan.
Protein A Immunoadsorption: an extracorporeal technique used for the removal of IgG antibodies and molecules.
Other drugs under investigation include Qiliqiangxin, Ranolazine, and Benazepril.^[1]

References

Overview